5-10
2026
影响因子区间
—
平台估算
10%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
【译文】由于临床脂质学的范围很广,该期刊涉及的主题同样多样化。典型的文章探讨在治疗环境中实践的脂质学、药物研究的最新进展、治疗和试验报告、案例研究、生活方式改变的影响以及实践者感兴趣的其他学术材料。虽然优先考虑具有直接实际应用价值的材料,但专家贡献的科学基础推动了脂质学,以便将基于证据的方法立即提供给读者。期刊的各个部分将涉及开创性研究及其执行者、案例研究、伦理标准和行为、专业指导如ATP和NCEP、编辑评论、读者来信、美国脂质协会(NLA)新闻和即将举行的活动信息,以及当适用时,NLA年度科学会议和其分会举办的科学论坛的摘要。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |